Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laia Richart
Observed names:
Laia Richart Ginés,
Laia Richart-Ginés,
Richart Ginés, Laia,
Richart-Ginés, Laia
Institutions:
Centre National de la Recherche Scientifique,
Inserm,
Université Paris Sciences et Lettres,
Génétique et biologie du développement,
Institut Curie
Observed institutions:
Centre National de la Recherche Scientifique,
Inserm,
University of Cambridge,
Université Paris Sciences et Lettres,
École Normale Supérieure - PSL,
Sorbonne Université,
Spanish National Cancer Research Centre,
Génétique et biologie du développement,
Institut Curie
show all 9
ORCID:
0000-0003-4593-3229
Observed ORCID:
0000-0003-4593-3229
OpenAlex ID:
A5002365286
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
2013
·
Cristina Balbás-Martínez
, Ana Sagrera
, et al.
·
Nature Genetics
·
273
BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis
2016
·
Laia Richart
, Enrique Carrillo-de Santa Pau
, et al.
·
Nature Communications
·
151
PDF
XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation
2022
·
Laia Richart
, Mary-Loup Picod-Chedotel
, et al.
·
Cell
·
69
PDF
Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 Mediator kinases
2020
·
Cian J. Lynch
, Raquel Bernad
, et al.
·
Nature Cell Biology
·
63
Drugging histone methyltransferases in cancer
2020
·
Laia Richart
, Raphaël Margueron
·
Current Opinion in Chemical Biology
·
48
PDF
STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells
2021
·
Laia Richart
, Eleonora Lapi
, et al.
·
Nucleic Acids Research
·
39
c-MYC partners with BPTF in human cancer
2016
·
Laia Richart
, Francisco X. Real
, et al.
·
Molecular & Cellular Oncology
·
27
PDF
H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2024
·
Valentina Ramponi
, Laia Richart
, et al.
·
Cancer Research
·
25
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
2024
·
Pierre Romero
, Laia Richart
, et al.
·
Nature Communications
·
25
PDF
c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis
2017
·
Victor J Sánchez-Arévalo Lobo
, Luis César Fernández
, et al.
·
Gut
·
24
Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming
2024
·
Yi-Ru Shen
, Sofia Zaballa
, et al.
·
Cell stem cell
·
23
Enhancer rewiring in tumors: an opportunity for therapeutic intervention
2021
·
Laia Richart
, François-Clément Bidard
, et al.
·
Oncogene
·
11
Bptf determines oncogenic addiction in aggressive B-cell lymphomas
2020
·
Laia Richart
, Irene Felipe
, et al.
·
Oncogene
·
11
A pattern emerges in chromatin aging: AP-1 steals the show
2024
·
Cian J. Lynch
, Laia Richart
, et al.
·
Cell Metabolism
·
7
PDF
Loss of XIST Impairs Human Mammary Stem Cell Differentiation and Increases Tumorigenicity Through Enhancer and Mediator Complex Hyperactivation
2021
·
Laia Richart
, Mary-Loup Picod
, et al.
·
SSRN Electronic Journal
·
2
Persister cancer cells are characterized by H4K20me3 heterochromatin that defines a low inflammatory profile
2024
·
Valentina Ramponi
, Laia Richart
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Figure S1 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Table S2 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Table S3 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Figure S4 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Table S5 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Figure S5 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Figure S2 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Figure S6 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Figure S7 from H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
2026
·
Valentina Ramponi
, Laia Richart
, et al.
Show more works
View as search
Works count:
55
Citation count:
798
H-index:
11
I10-index:
13
Year
Topic
Type